Un1Cas12f1,

Yanan Huo1, Jiale Mei1, Dan Zhang1

  • 1Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, China.

Nature communications
|February 18, 2026
PubMed
概括

工程CRISPR-Cas12f (evoCas12f) 扩展了PAM识别并提高了基因编辑效率. 这种优化的系统可以实现精确的基因组工程,包括小鼠的同卵性突变,从而推进治疗应用.